<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=549090&amp;fmt=gif">
Webinar On Demand: From Concept to Compliance - Navigating Risk and Regulatory Submissions Across the Life Sciences Blog Feature
Cognition Corporation

By: Cognition Corporation on August 1st, 2025

Print/Save as PDF

Webinar On Demand: From Concept to Compliance - Navigating Risk and Regulatory Submissions Across the Life Sciences

FDA | Product Development | Industry Updates | Risk Management | Webinar | Compass BIO | Biopharma

If you missed our recent panel discussion, “From Concept to Compliance: Navigating Risk and Regulatory Submissions Across the Life Sciences,” the full recording is now available to watch on demand.

In this conversation hosted by Cognition Corporation and AVS Life Sciences, regulatory, quality, and technology experts came together to explore how MedTech, Biopharma, and combination product teams can break down silos, manage risk proactively, and streamline submission readiness.

Featuring insights from industry leaders, the panel covers:

  • Real-world compliance breakdowns—and how to avoid them

  • Best practices for integrating risk across the product lifecycle

  • The limitations of legacy tools like Excel, and the benefits of purpose-built platforms

  • How to foster transparency, collaboration, and data integrity in today’s complex development environment

Whether you’re leading a submission strategy or just trying to keep up with today’s FDA expectations, this discussion is packed with practical advice and lessons learned.

Watch the webinar now by clicking below.

 

 

About Cognition Corporation

At Cognition, our goal is to provide medical device and pharmaceutical companies with collaborative solutions to the compliance problems they face every day, allowing the customer to focus on their products rather than the system used to create them. We know we are successful when our customers have seamlessly integrated a quality system, making day-to-day compliance effortless and freeing up resources to focus on product safety and efficacy.

  • Connect with Cognition Corporation